Align Technology, Inc. (ALGN) Given Buy Rating at Stifel Nicolaus

Stifel Nicolaus reissued their buy rating on shares of Align Technology, Inc. (NASDAQ:ALGN) in a research note issued to investors on Monday, August 7th. The firm currently has a $205.00 price objective on the medical equipment provider’s stock, up from their previous price objective of $200.00.

ALGN has been the subject of several other reports. Morgan Stanley reissued an overweight rating and set a $175.00 price target on shares of Align Technology in a report on Monday, June 19th. They noted that the move was a valuation call. Leerink Swann raised their price objective on shares of Align Technology from $149.00 to $194.00 and gave the company an outperform rating in a research report on Monday, June 26th. Northcoast Research restated a buy rating and issued a $186.00 price objective (up previously from $164.00) on shares of Align Technology in a research report on Wednesday, June 21st. Robert W. Baird upgraded shares of Align Technology from a neutral rating to an outperform rating and raised their price objective for the company from $105.00 to $155.00 in a research report on Friday, April 28th. Finally, Piper Jaffray Companies restated a buy rating and issued a $176.00 price objective on shares of Align Technology in a research report on Friday, July 28th. Ten research analysts have rated the stock with a buy rating, The stock has a consensus rating of Buy and a consensus target price of $174.40.

Shares of Align Technology (NASDAQ ALGN) traded down 0.44% during midday trading on Monday, hitting $168.61. 1,393,519 shares of the stock were exchanged. Align Technology has a 12-month low of $83.27 and a 12-month high of $179.76. The firm has a market cap of $13.51 billion, a P/E ratio of 57.74 and a beta of 1.55. The stock’s 50 day moving average is $162.73 and its 200 day moving average is $132.63.

Align Technology (NASDAQ:ALGN) last released its quarterly earnings data on Thursday, July 27th. The medical equipment provider reported $0.85 EPS for the quarter, topping analysts’ consensus estimates of $0.73 by $0.12. The company had revenue of $356.50 million during the quarter, compared to the consensus estimate of $343.43 million. Align Technology had a net margin of 19.18% and a return on equity of 23.87%. The firm’s revenue for the quarter was up 32.3% compared to the same quarter last year. During the same period last year, the firm earned $0.62 EPS. On average, equities research analysts forecast that Align Technology will post $3.40 earnings per share for the current fiscal year.

TRADEMARK VIOLATION WARNING: “Align Technology, Inc. (ALGN) Given Buy Rating at Stifel Nicolaus” was originally reported by BNB Daily and is owned by of BNB Daily. If you are reading this piece on another publication, it was illegally stolen and reposted in violation of U.S. & international copyright law. The correct version of this piece can be viewed at https://www.baseball-news-blog.com/2017/08/19/align-technologys-algn-buy-rating-reaffirmed-at-stifel-nicolaus-updated.html.

In other Align Technology news, Director Joseph Lacob sold 50,000 shares of Align Technology stock in a transaction that occurred on Wednesday, May 31st. The shares were sold at an average price of $144.98, for a total value of $7,249,000.00. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, VP Sreelakshmi Kolli sold 1,000 shares of Align Technology stock in a transaction that occurred on Tuesday, May 30th. The shares were sold at an average price of $144.00, for a total transaction of $144,000.00. Following the completion of the transaction, the vice president now directly owns 23,785 shares in the company, valued at approximately $3,425,040. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 54,874 shares of company stock valued at $7,950,701. Corporate insiders own 2.00% of the company’s stock.

A number of hedge funds and other institutional investors have recently made changes to their positions in ALGN. Vanguard Group Inc. raised its position in shares of Align Technology by 16.5% in the second quarter. Vanguard Group Inc. now owns 7,299,099 shares of the medical equipment provider’s stock worth $1,095,740,000 after buying an additional 1,034,254 shares during the last quarter. BlackRock Inc. raised its stake in shares of Align Technology by 5,738.0% in the first quarter. BlackRock Inc. now owns 6,640,531 shares of the medical equipment provider’s stock worth $761,737,000 after buying an additional 6,526,784 shares in the last quarter. Polen Capital Management LLC raised its stake in shares of Align Technology by 6.8% in the second quarter. Polen Capital Management LLC now owns 3,362,570 shares of the medical equipment provider’s stock worth $504,789,000 after buying an additional 212,773 shares in the last quarter. State Street Corp raised its stake in shares of Align Technology by 32.2% in the second quarter. State Street Corp now owns 3,143,095 shares of the medical equipment provider’s stock worth $471,823,000 after buying an additional 765,189 shares in the last quarter. Finally, Renaissance Technologies LLC raised its stake in shares of Align Technology by 11.3% in the second quarter. Renaissance Technologies LLC now owns 1,587,681 shares of the medical equipment provider’s stock worth $238,343,000 after buying an additional 160,881 shares in the last quarter. 88.07% of the stock is currently owned by hedge funds and other institutional investors.

About Align Technology

Align Technology, Inc designs, manufactures and markets a system of clear aligner therapy, intra-oral scanners and computer-aided design/computer-aided manufacturing (CAD/CAM) digital services used in dentistry, orthodontics and dental records storage. The Company operates through two segments: Clear Aligner segment and Scanner and Services (Scanner) segment.

Analyst Recommendations for Align Technology (NASDAQ:ALGN)

Receive News & Ratings for Align Technology Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Align Technology Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply